Amonoo H, Onyeaka H, Onyema C & Evins AE. (2024). Associations between health-related use of social media and positive lifestyle behaviors: Findings from a representative sample of US adult smokers. Subst Use Misuse. 2024;59(4):527-535. https://doi.org/10.1080/10826084.2023.2287199

Browne J, Elbogen EB, Mueser KT, Rudolph JL, Wu WC, Philip NS, Mills WL, Young AS, Sloane R & Hall KS. (2024). Trajectories of physical function changes for older veterans with serious mental illness in a clinical exercise program. Mental Health and Physical Activity, 26, 100580. https://doi.org/10.1016/j.mhpa.2024.100580

Charlton BM, Potter J, Keuroghlian AS, Dalrymple JL, Katz-Wise SL, Guss CE, Phillips WR, Jarvie E, Maingi S, Streed C, Anglemyer E, Hoatson T & Birren B. (2024). Development of a mentor training curriculum to support LGBTQIA+ health professionals. J Clin Transl Sci; 8(1):e44. https://doi.org/10.1017/cts.2024.18

Chinbunchorn T, Mayer KH, Campbell J, King D, Krakower D, Marcus JL, Grasso C & Keuroghlian AS. (2024). HIV Pre-exposure prophylaxis provision by U.S. health centers in 2021. AIDS, 38(3):415-420. https://doi.org/10.1097/qad.0000000000003774

Clauss JA, Foo CYS, Leonard CJ, Dokhoylan N, Cather C & Holt DJ. (2024). Screening for psychotic experiences and psychotic disorders in general psychiatric settings: A systematic review and meta-analysis. medRxiv. Preprint. https://doi.org/10.1101/2024.04.14.24305796

Cooke ME, Knoll SJ, Streck JM, Potter K, Lamberth E, Rychik N, Gilman JM, Evins AE & Schuster RM. (2024). Contingency management is associated with positive changes in attitudes and reductions in cannabis use even after discontinuation of incentives among non-treatment seeking youth. Drug and Alcohol Dependence, 256, 111096.  https://doi.org/10.1016/j.drugalcdep.2024.111096

DeTore NR, Burke A, Nyer M, & Holt DJ. (2024). A brief resilience-enhancing intervention and loneliness in at-risk young adults: A secondary analysis of a randomized clinical trial. JAMA Network Open, 7(2), e2354728. https://doi.org/10.1001/jamanetworkopen.2023.54728

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van Alphen MU & Stern TA. (2024). Assessment and treatment of abnormal involuntary Movements. Harv Rev Psychiatry, 32(2), 47-57. https://doi.org/10.1097/hrp.0000000000000390

Foo CYS, Potter K, Nielsen L, Rohila A, Maravic MC, Schnitzer K, Pachas GN, Levy DE, Reyering S, Thorndike AN, Cather C & Evins AE. (2024). Implementation of community health worker support for tobacco cessation: A mixed-methods study. medRxiv, 2024.01.26.24301835. https://doi.org/10.1101/2024.01.26.24301835 Preprint. 

Karunakaran KD, Pascale M, Ozana N, Potter K, Pachas GN, Evins AE, Gilman JM. (2024). Intoxication due to ∆9-tetrahydrocannabinol (THC) is characterized by disrupted prefrontal cortical connectivity: A randomized clinical trial. Neuropsychopharmacology, 49(9), 1481–1490. https://doi.org/10.1038/s41386-024-01876-5  

Keuroghlian AS, Marc L, Goldhammer H, Massaquoi M, Downes A, Stango J, Bryant H, Cahill S, Perez AC, Head JM, Mayer KH, Myers J, Rebchook GM, Bourdeau B, Psihopaidas D, Chavis NS & Cohen SM. (2024). A peer-to-peer collaborative learning approach for the implementation of evidence-informed interventions to improve HIV-related health outcomes. AIDS and Behavior. https://doi.org/10.1007/s10461-023-04260-4

Keuroghlian AS. (2024). Cisgender privilege in public health research. Am J Public Health, 114(2), 142–143. https://doi.org/10.2105/AJPH.2023.307542

Lester M, Scanlon F & Batastini A. (2024). Doubling down on dosage: exploring the interplay between dosage effects, antisocial traits, treatment attitudes, and recidivism-related therapy outcomes. Journal of Criminal Psychology. Online ahead of print. https://doi.org/10.1108/JCP-01-2024-0005

Lim C, Donovan A, Freudenreich S, Cather C, Maclaurin S & Freudenreich O. (2024). Second opinions in psychotic disorders: Delivering stage-specific recommendations. Psychiatric Services, appips20230623. Online ahead of print. https://doi.org/10.1176/appi.ps.20230623

Liu M, Grasso C, Kim H-H, Mayer KH & Keuroghlian AS. (2024). Advancing pediatric sexual orientation and gender identity data collection. American Journal of Public Health, 114(1), 17-20. https://doi.org/10.2105/ajph.2023.307448  

Liu M, Patel VR, Reisner SL & Keuroghlian AS. (2024). Health status and mental health of transgender and gender-diverse adults. JAMA Intern Medicine, 184(8), 984-986. https://doi.org/10.1001/jamainternmed.2024.2544  

Lu W, Caldwell B, Gao N, Oursler J, Wang K, Beninato J, Srijeyanthan J, Kumi C, Sawyer J, Giacobbe G & Mueser KT. (2024.). Healing trauma while staying at home: Using telehealth to conduct a brief treatment program for PTSD. Journal of Psychosocial Nursing and Mental Health Services, 62(7), 36–46. https://doi.org/10.3928/02793695-20231205-01

Mayer K, Peretti M, McBurnie MA, King D, Smith N, Crawford P, Loo S, Sigal M, Gillespie S, Davis J, Cahill S, Grasso C & Keuroghlian AS. (2024). Training health center staff in the provision of culturally responsive care for sexual and gender minority patients: Results of a randomized controlled trial. LGBT Health, 11(2), 131-142. https://doi.org/10.1089/lgbt.2022.0322

Meza BPL, Pollack CE, Tilchin C, Jennings JM, Latkin CA, Cather C, Dickerson F, Evins AE, Wang NY, Daumit GL, Yuan C & Gudzune KA. (2024). Social networks of people with serious mental illness who smoke: Potential role in a smoking cessation intervention. Journal of Mental Health, 1–10. https://doi.org/10.1080/09638237.2024.2332807

Mitnick S, Goldhammer H, Thompson J, Bruno J, Dunn M, Reisner SL & Keuroghlian AS. (2023). Advancing excellence in transgender health: An international professional development conference on affirming care for transgender and gender diverse people. Journal of Medical Education and Curricular Development, 10. https://doi.org/10.1177/23821205231191478  

Mosier-Mills A, Kim H & Keuroghlian AS. (2024). Removing barriers and honoring autonomy: Rethinking mental health professional assessments in adolescent gender-affirming medical care. Harvard Review of Psychiatry, 32(3), 96–100. https://doi.org/10.1097/HRP.0000000000000397

Petriceks A, Vyas CM, Paudel S, Donovan AL, Van Alphen MU & Stern TA. (2024). Assessment and treatment of abnormal involuntary movements. Harv Rev Psychiatry, 32(2):47-57. https://doi.org/10.1097/hrp.0000000000000390  

Pletta DR, Austin SB, Chen JT, Radix AE, Keuroghlian AS, Hughto JMW & Reisner SL. (2024). Lower levels of social support are associated with risk for future suicide attempts in a clinical sample of transgender and gender diverse adults. Soc Psychiatry Psychiatr Epidemiol. Advance online publication. https://doi.org/10.1007/s00127-023-02606-w

Reisner SL, Deutsch MB, Mayer KH, Campbell J, Potter J, Keuroghlian AS, Hughto JMW, Asquith A, Pardee DJ, Harris A, Quint M, Grasso C, Gonzalez A & Radix A. (2024). Decreased anogenital gonorrhea and chlamydia in transgender and gender diverse primary care patients receiving gender-affirming hormone therapy. J Gen Intern Med, 39(7), 1164–1172. https://doi.org/10.1007/s11606-023-08531-7

Sandhu S, Liu M & Keuroghlian AS. (2024). Strategies for insurers to promote sexual and gender minority health. JAMA Health Forum, 5(4), e240439. https://doi.org/10.1001/jamahealthforum.2024.0439

Scanlon F, Morgan RD & Aceves D. (2024). Implementing a treatment for people with serious mental illness in jail: A mixed-methods study of stakeholder perspectives on feasibility and acceptability. Adm Policy Ment Health. https://doi.org/10.1007/s10488-024-01380-4

Schnabel D & Keuroghlian AS. (2024). Clinical considerations for children of lesbian, gay, bisexual, transgender, queer, intersex, asexual, and all sexually and gender diverse families. LGBT Health.Epub ahead of print. https://doi.org/10.1089/lgbt.2023.0225

Shin A, Kathrins M & Keuroghlian AS. (2024). Systemic barriers to fertility preservation for sexually and gender diverse populations. LGBT Health, 10.1089/lgbt.2023.0317. Advance online publication. https://doi.org/10.1089/lgbt.2023.0317

Srinivasan S, Goldhammer H, Charlton BM, McKenney T & Keuroghlian AS. (2024). Addressing gaps in access to LGBTQIA+ health education resources: A novel e-learning platform. J Med Educ Curric Dev, 11, 23821205241262212. https://doi.org/10.1177/23821205241262212

Streck JM, Potter K, Pachas GN, Cather C, Nielsen L & Evins AE. (2024). Alternative combusted tobacco product and multiple tobacco product use among individuals with serious mental illness enrolled in a large pragmatic randomized controlled trial. Addict Behav, 148, 107844. https://doi.org/10.1016/j.addbeh.2023.107844

Tervo-Clemmens B, Bentley K, Smoller JW, Nock M, Evins AE, Gilman JM & Schuster RM. (2024). Substance use is dose dependently associated with suicidal thoughts and psychiatric comorbidities. JAMA pediatrics, 178(3), 310–313. https://doi.org/10.1001/jamapediatrics.2023.6263

Tervo-Clemmens B, Pachas GN, Evins AE, Gilman JM & Schuster RM. (2024). The developmental timing but not magnitude of adolescent risk-taking propensity is consistent across social, environmental, and psychological factors. J Adolesc Health, 74(3), 613–616. https://doi.org/10.1016/j.jadohealth.2023.11.001  

Winickoff J, Evins AE & Levy S. (2024). Vaping in youth. JAMA , 332(9), 749-750. https://doi.org/10.1001/jama.2024.13403

Wu CA, Ho I, Minasian A, Keuroghlian AS, O’Brien-Coon D & Ranganathan K (2024). Variability in Medicaid coverage for gender-affirming surgeries across US States. Annals of Surgery, 279(3), 542–548. https://doi.org/10.1097/SLA.0000000000005974

Ard KL, Bruno J, Uzoeghelu U, Lambert C, Khan T, Davis JA, Mayer KH & Keuroghlian AS. (2023). PrEP ECHO: A national interdisciplinary telementoring program for HIV prevention through practice transformation. AIDS Education and Prevention, 35(3), 247-253. https://doi.org/10.1521/aeap.2023.35.3.247

Baumer AM, Nestor BA, Potter K, Knoll S, Evins AE, Gilman J, Kossowsky J, Schuster RM. (2023). Assessing changes in sleep across four weeks among adolescents randomized to incentivized cannabis abstinence. Drug Alcohol Depend. 252:110989. https://doi.org/10.1016/j.drugalcdep.2023.110989  

Blajeski S, Smith MJ, Harrington M, Johnson J, Oulvey EA, Mueser KT, McGurk SR, & Razzano LA. (2023). Critical elements in the experience of virtual reality job interview training for unemployed individuals with serious mental illness: Implications for IPS supported employment. Psychiatric rehabilitation journal, 10.1037/prj0000574. Advance online publication. https://doi.org/10.1037/prj0000574

Blajeski S, Smith MJ, Harrington M, Johnson J, Ross B, Weaver A, Razzano LA, Jordan N, Oulvey EA, Mueser KT, McGurk SR, Bell MD, & Smith JD (2023). A mixed-method implementation evaluation of virtual reality job interview training for individuals with serious mental illness in IPS supported employment. Psychiatric Services (Washington D.C.), 75(3), 228-236. https://doi.org/10.1176/appi.ps.20230023  

Botello R, Gill K, Mow JL, Leung L, Mote J, Mueser KT, Gard DE & Fulford D. (2023). Validation of the Social Effort and Conscientious Scale (SEACS) in schizophrenia. J Psychopathol Behav Assess. https://doi.org/10.1007/s10862-023-10031-1

Bruno J, Vedilago V, Goldhammer H, Campbell J & Keuroghlian AS. (2023). TransECHO: A national tele-education program for expanding transgender and gender diverse health care. LGBT Health, 10(6). https://doi.org/10.1089/lgbt.2022.0355

Butler W, Kim H & Keuroghlian AS. (2023). Psychiatric boarding of transgender and gender diverse youth awaiting treatment. LGBT Health, 10(6). https://doi.org/10.1089/lgbt.2022.0267

Cooke ME, Potter KW, Jashinski J, Pascale M, Schuster RM, Tervo-Clemmens B, Hoeppner BB, Pachas GN, Evins AE, Gilman JM. (2023). Development of cannabis use disorder in medical cannabis users: A 9-month follow-up of a randomized clinical trial testing effects of medical cannabis card ownership. Front Psychiatry, 14.  https://doi.org/10.3389/fpsyt.2023.1083334

Daumit GL, Evins AE, Cather C, Dalcin AT, Dickerson FB, Miller ER 3rd, Appel LJ, Jerome GJ, McCann U, Ford DE, Charleston JB, Young DR, Gennusa JV 3rd, Goldsholl S, Cook C, Fink T & Wang NY. (2023). Effect of a Tobacco Cessation Intervention Incorporating Weight Management for Adults With Serious Mental Illness: A Randomized Clinical Trial. JAMA Psychiatry, 80(9):895–904.https://doi.org/10.1001/jamapsychiatry.2023.1691

Delman J, Arntz D, Whitman A, Skiest H, Kritikos K, Alves P, Chambers V, Markley R, Martinez J, Piltch C, Whitney-Sarles S, London J, Shtasel D & Cather C. (2023). Using community-based participatory research to conduct a collaborative needs assessment of mental health service users: Identifying research questions and building academic-community trust. Health Promotion Practice. https://doi.org/10.1177/15248399231171144

Dickerson F, Goldsholl S, Yuan CT, Dalcin AT, Eidman B, Minahan E, Gennusa JV, Mace E, Cullen B, Evins AE, Cather C, Wang NY, McGinty EM & Daumit GL. (2023). Promoting evidence-based tobacco cessation treatment in community mental health clinics: Protocol for a pilot study. JMIR Research Protocols, 12:e44787.  https://doi.org/10.2196/44787

Donovan A. (2023). Psychiatric boarding trends among publicly insured youths during the COVID-19 pandemic—The other pandemic. JAMA Network Open, 6(7), e2321754.https://doi.org/10.1001/jamanetworkopen.2023.21754

Donovan AL, Petriceks AH, Paudel S, Vyas CM & Stern TA. (2023). Use of physical restraints in the emergency department: Rationale, risks, and benefits. The Primary Care Companion for CNS disorders, 25(3), 22f03320.  https://doi.org/10.4088/PCC.22f03320

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van Alphen MU & Stern TA. (2023). Drug-induced abnormal involuntary movements: Prevalence and treatment. The Primary Care Companion for CNS disorders, 25(3):22f03305.  https://doi.org/10.4088/PCC.22f03305

Espi Forcen F & Freudenreich O. (2023). Coping with pandemics: A historical perspective about society’s tools to deal with global infectious diseases. J Nerv Ment Dis, 211(12), 927-933. https://doi.org/10.1097/nmd.0000000000001668

Foo CYS, Gaudiano BA, Friedman-Yacoobian M & Yen S. (2023). Acceptance-based Parent Training Intervention for Youths with Co-occurring Psychotic Symptoms and Suicidal Behaviors: A Case Series from an Open Trial. International Journal of Cognitive Behavioral Therapy 17(4). https://doi.org/10.1007/s41811-023-00181-1

Forcen F & Freudenreich O. (2023). Coping with pandemics: A historical perspective about society’s tools to deal with global infectious diseases. The Journal of Nervous and Mental Disease, 211(12), 927-933. https://doi.org/10.1097/NMD.0000000000001668

Fortuna KL, Lebby S, Geiger P, Johnson D, MacDonald S, Chefetz I, Ferron JC, St George L, Rossom R, Kalisa J, Mestrovic T, Nicholson J, Pringle W, Rotondi AJ, Sippel LM, Sica A, Solesio ME, Wright M, Zisman-Ilani Y, Cather C & Walker R. (2023). Lived experience–led research agenda to address early death in people with a diagnosis of a serious mental illness. JAMA Netw. Open, 6(5):e2315479. https://doi.org/10.1001/jamanetworkopen.2023.15479

Fulford D & Holt DJ (2023). Social withdrawal, loneliness, and health in schizophrenia: Psychological and neural mechanisms. Schizophrenia Bulletin, 49(5), 1138-1149. https://doi.org/10.1093/schbul/sbad099 

Gilman JM, Potter K, Schuster RM, Hoeppner BB & Evins AE (2023). Cannabis use for medical symptoms: Patterns over the first year of use. Addictive Behaviors, 144, 107719. https://doi.org/10.1016/j.addbeh.2023.107719  

Guy AA, Surace A, Zelaya DG, Flynn R, Opalo C, Keuroghlian AS, Mayer KH, Monti PM & Kahler CW. (2023). Transgender and gender diverse adults’ reflections on alcohol counseling and recommendations for providers. American Journal of Orthopsychiatry. https://doi.org/10.1037/ort0000663   

Kamal K, Keuroghlian AS & Potter J. (2023). Promoting sexual and gender minority health clinical skills training for all medical students. Academic Medicine: Journal of the Association of American Medical Colleges, 98(9), 987-993). https://doi.org/10.1097/ACM.0000000000005240

Kamal K, Li JJ & Keuroghlian AS. (2023). Addressing the physical and mental impacts of post-surgical scarring among transgender and gender diverse people. LGBT Health. https://doi.org/10.1089/lgbt.2022.0308

Keuroghlian AS, Marcus PH, Neufeld J, Phillips E, Grasso C & Wozniak JR. (2023). Telehealth for psychiatry and mental health care can improve access and patient outcomes. Nature Medicine, 29(11), 2698–2700. https://doi.org/10.1038/s41591-023-02579-y  

Keuroghlian AS. (2023). Countering the health disinformation machine. N Engl J Med, 389(14), 1256-1258. https://doi.org/10.1056/nejmp2307572  

Kim H, Goetz TG, Grieve V & Keuroghlian AS. (2023). Psychopharmacological considerations for gender-affirming hormone therapy. Harvard Review of Psychiatry, 31(4), 183–194. https://doi.org/10.1097/HRP.0000000000000373

Lim C, Patel SK & Freudenreich O. (2023). Adult-onset stuttering in schizophrenia with catatonia that responded to electroconvulsive therapy. J Acad Consult Liaison Psychiatry, 64(4), 407-408. https://doi.org/10.1016/j.jaclp.2023.03.004  

Liu M, King D, Mayer KH, Grasso C & Keuroghlian AS. (2023). Sexual orientation and gender identity data completeness at US federally qualified health centers, 2020 and 2021. American Journal of Public Health, e1–e10.  https://doi.org/10.2105/AJPH.2023.307323

Liu M, Sandhu S, Reisner SL, Gonzales G & Keuroghlian AS. (2023). Health status and healthcare access among lesbian, gay, and bisexual adults in the US, 2013-2018. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2022.6523

Loo S, Peretti M, Sigal M, Noe B, Grasso C, Keuroghlian AS & Mayer KH. (2023). Health center leadership perspectives regarding barriers to and facilitators of providing culturally responsive care for sexual and gender minority patients. LGBT Health. Online ahead of print.  http://doi.org/10.1089/lgbt.2022.0135

Lu W, Caldwell B, Gao N, Oursler J, Wang K, Beninato J, Srijeyanthan J, Kumi C, Sawyer J, Giacobbe G & Mueser KT. (2023). Healing trauma while staying at home: Using telehealth to conduct a brief treatment program for PTSD.  Journal of Psychosocial Nursing and Mental Health Services, 0(0):1–11. https://doi.org/10.3928/02793695-20231205-01

McDowell MJ, King DS, Gitin S, Miller AS, Batchelder AW, Busch AB, Greenfield SF, Huskamp HA & Keuroghlian AS. (2023). Alcohol use disorder treatment in sexually and gender diverse patients. J Clin Psychiatry, 84(5). https://doi.org/10.4088/jcp.23m14812  

Mueser KT, Sussman RF, DeTore NR, & McGurk SR. (2023). The impact of early intervention for first episode psychosis on cognitive functioning. Schizophrenia Research, 260, 132–139. https://doi.org/10.1016/j.schres.2023.07.021  

Nagendra A, Black C & Penn DL. (2023). Black Americans and schizophrenia: Racism as a driver of inequities in diagnosis, assessment, and treatment. Schizophrenia Research, 253, 1–4. https://doi.org/10.1016/j.schres.2022.10.007

Nagendra A, Liu C-WJ, Mueser KT, Harvey PD, Depp C, Moore R, Davis B, & Pinkham A. (2023). Do symptom severity, individual socioeconomic status, and neighborhood socioeconomic status explain differences in daily functioning in non-Latinx Black, non-Latinx white, and Latinx people with serious mental illnesses? Clinical Psychological Science, 0(0). https://doi.org/10.1177/21677026231169659

Nagendra A, Weiss DM, Merritt C, Cather C, Sosoo EE, Mueser KT & Penn DL. (2023). Clinical and psychosocial outcomes of Black Americans in the Recovery After an Initial Schizophrenia Episode Early Treatment Program (RAISE-ETP) study. Social psychiatry and psychiatric epidemiology, 58(1), 77–89. https://doi.org/10.1007/s00127-022-02297-9

Ng LC, Miller AN, Bowers G, Cheng Y, Brigham R, Tai MH, Smith AM, Mueser KT, Fortuna LR & Coles M. (2023). A pragmatic feasibility trial of the Primary Care Intervention for PTSD: A health service delivery model to reduce health disparities for low-income and BIPOC youth. Behaviour Research and Therapy, 165, 104310.  https://doi.org/10.1016/j.brat.2023.104310

Ørjasæter KB & Mueser KT. (2023). Meaningful goal setting: Practitioners’ perspectives on goal setting in the illness management and recovery program. Psychiatric Rehabilitation Journal, 46(1), 94-100. http://dx.doi.org/10.1037/prj0000564

Orozco-Poore C & Keuroghlian AS. (2023). Neurological considerations for “nerve-sparing” cosmetic genital surgeries performed on children with xx chromosomes diagnosed with 21-hydroxylase congenital adrenal hyperplasia and clitoromegaly. LGBT Health, 8(10). https://doi.org/10.1089/lgbt.2022.0160

Paudel S, Donovan AL, Petriceks A, Vyas CM, Van MU & Stern TA. (2023). Drug-induced abnormal involuntary movements: Prevalence and treatment. The Primary Care Companion for CNS Disorders, 25(3), 22f03305.  https://doi.org/10.4088/PCC.22f03305

Schuster RM, Cather C, Pachas GN, Nielsen L, Iroegbulem V, Dufour J, Potter K, Levy S, Gray KM & Evins AE (2023). A randomized controlled trial of varenicline and brief behavioral counseling delivered by lay counselors for adolescent vaping cessation: Study protocol. Frontiers in Psychiatry, 14, 1083791. https://doi.org/10.3389/fpsyt.2023.1083791  

Schwartz KR, Donovan AL, Hayes BD, Uchida M & Rosen JB. (2023). Case 16-2023: A 13-year-old boy with depression and hypotension. The New England Journal of Medicine, 388(21), 1992–1999. https://doi.org/10.1056/NEJMcpc2201237

Scott K, Guy AA, Zelaya DG, Surace A, Elwy AR, Keuroghlian AS, Mayer KH, Monti PM & Kahler CW. (2023). Research and engagement considerations for alcohol use telehealth services within HIV care: A qualitative exploration on federally qualified health centers. AIDS Care. https://doi.org/10.1080/09540121.2023.2197640

Senay O, Seethaler M, Makris N, Yeterian E, Rushmore J, Cho KIK, Rizzoni E, Heller C, Pasternak O, Szczepankiewicz F, Westin CF, Losak J, Ustohal L, Tomandl J, Vojtisek L, Kudlicka P, Kikinis Z, Holt DJ, Lewandowski KE, Lizano P, Keshavan MS, Öngür D, Kasparek T, Breier A, Shenton ME, Seitz-Holland J & Kubicki M. (2023). A preliminary choroid plexus volumetric study in individuals with psychosis. Hum Brain Mapp. 44(6):2465-2478.  https://doi.org/10.1002/hbm.26224

Smith MJ, Burke-Miller JK, Bornheimer LA, Ross B, Bell MD, McGurk SR, Mueser KT, Nelson K, Brown A, Prestipino J, Borghani N & Razzano LA. (2023). Psychometric properties of the mock interview rating scale for schizophrenia and other serious mental illnesses. Frontiers in psychiatry, 14, 1150307. https://doi.org/10.3389/fpsyt.2023.1150307

Streck JM, Regan S, Werner M, Glynn A, Villanti AC, Park ER, Wakeman SE, Evins AE & Rigotti NA (2023). Preliminary feasibility of integrating tobacco treatment into SUD peer recovery coaching: a mixed-methods study of peer recovery coaches. Addiction Science & Clinical Practice, 18(1), 25. https://doi.org/10.1186/s13722-023-00380-3  

Tervo-Clemmens B, Schmitt W, Wheeler G, Cooke ME, Schuster RM, Hickey S, Pachas GN, Evins AE & Gilman JM. (2023). Cannabis use and sleep quality in daily life: An electronic daily diary study of adults starting cannabis for health concerns. Drug and alcohol dependence, 243, 109760. https://doi.org/10.1016/j.drugalcdep.2022.109760

Turban JL, Dolotina B, Freitag TM, King D & Keuroghlian AS. (2023). Age of realization and disclosure of gender identity among transgender adults. The Journal of Adolescent Health : Official publication of the Society for Adolescent Medicine, 72(6), 852–859.  https://doi.org/10.1016/j.jadohealth.2023.01.023

Van Alphen, MU, Lim C & Freudenreich O. (2023). Mobile vaccine clinics for patients with serious mental illness and health care workers in outpatient mental health clinics. Psychiatr Serv. https://doi.org/10.1176/appi.ps.20220460

Vyas CM, Petriceks AH, Paudel S, Donovan AL, & Stern TA. (2023). Acute psychosis: Differential diagnosis, evaluation, and management. The Primary Care Companion for CNS Disorders, 25(2), 22f03338. https://doi.org/10.4088/PCC.22f03338

Weiss JH, Tervo-Clemmens B, Evins AE, Gilman JM (2023). The Cannabis Effects Expectancy Questionnaire–Medical (CEEQ–M): Preliminary psychometric properties and longitudinal validation within a clinical trial. Psychological Assessment 35(8), 659–673. https://doi.org/10.1037/pas0001244

Wright AC, Palmer-Cooper E, Cella M, McGuire N, Montagnese M, Dlugunovych V, Liu CJ, Wykes T & Cather C. (2023). Experiencing hallucinations in daily life: The role of metacognition. Schizophrenia Research, 265, 74-82.  https://doi.org/10.1016/j.schres.2022.12.023

Alegria M, Falgas-Bague I, Fukuda M, Zhen-Duan J, Weaver C, O’Malley I, Layton T, Wallace J, Zhang L, Lapatin Markle S, Neighbors C, Lincourt P, Hussain S, Manseau M, Stein B, Rigotti N, Wakeman S, Kane M, Evins AE, McGuire T. (2022). Performance metrics of substance use disorder care among Medicaid enrollees in New York City: Your managed care plan can make a difference. JAMA health forum, 3(7), e221771. https://doi.org/10.1001/jamahealthforum.2022.1771

AS Keuroghlian, Keatley J, Shaikh S & Radix AE. (2022). The context, science, and practice of gender-affirming care. Nature Medicine, 28(12), 2464–2467. https://doi.org/10.1038/s41591-022-02082-w

Browne J, Cather C & Ponce AN. (2022). A preliminary study of clinical psychology doctoral students’ training in food insecurity assessment and resource provision. Journal of Health Care for the Poor and Underserved, 33(2), 623–632. https://doi.org/10.1353/hpu.2022.0052

Clauss J, Bhiku K, Burke A, Pimentel-Diaz Y, DeTore N, Zapetis S, Zvonar V, Kritikos K, Canenguez K, Cather C & Holt D. (2022). Development of a transdiagnostic, resilience-focused intervention for at-risk adolescents. Journal of Mental Health, 32(3), 592-601. https://doi.org/10.1080/09638237.2022.2140790

Cooke ME, Clifford JS, Do EK, Gilman J, Maes HH, Peterson RE, Prom-Wormley EC, Spit for Science Working group, Evins AE, Schuster RM. (2022). Polygenic score for cigarette smoking is associated with ever electronic-cigarette use in a college-aged sample. Addiction (Abingdon, England), 117(4), 1071–1078. https://doi.org/10.1111/add.15716

de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, Kopeček M, Švancer P, Olmos I, Ricciardi C, Iglesias-Garcia C, Iglesias-Alonso A, Spina E, Ruan CJ, Wang CY, Wang G, Tang YL, Lin SK, Lane HY, Kim YS, …Freudenreich O, …Müller DJ. (2022). An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry, 55(2), 73–86. https://doi.org/10.1055/a-1625-6388

DeTore NR, Bain K, Wright A, Meyer-Kalos P, Gingerich S, & Mueser KT. (2022). A randomized controlled trial of the effects of early intervention services on insight in first episode psychosis. Schizophrenia Bulletin, 48(6), 1295-1305. https://doi.org/10.1093/schbul/sbac099

DeTore NR, Balogun-Mwangi O, Tepper M, Cather C, Russinova Z, Lanca M & Mueser KT. (2022). The interrelationships of motivation, positive symptoms, stigma, and role functioning in early psychosis.Early Intervention in Psychiatry, 16(7), 736–743.  https://doi.org/10.1111/eip.13213

DeTore NR, Luther L, Deng WY, Zimmerman JE, Leatham L, Burke A, Nyer MB, Holt DJ. (2022). Efficacy of a transdiagnostic, prevention-focused program for at-risk young adults: a waitlist-controlled trial. Psychological Medicine, 1–10.  https://doi.org/10.1017/S0033291722000046

Donovan AL, Vyas CM, Petriceks A, Paudel S, Van MU & Stern TA. (2022). Agitation and an altered mental status in the emergency department: Differential diagnosis, evaluation, and treatment. The primary care companion for CNS disorders, 24(6), 22f03277.  https://doi.org/10.4088/PCC.22f03277

Dotson S, Johnson-Arbor K, Schuster R, Tervo-Clemmens B, Evins AE. (2022). Unknown risks of psychosis and addiction with delta-8-THC: A call for research, regulation, and clinical caution. Addiction (Abingdon, England), 117(9), 2371–2373. https://doi.org/10.1111/add.15873

Eryilmaz H, Pax M, O’Neill AG, Vangel M, Diez I, Holt DJ, Camprodon JA, Sepulcre J & Roffman JL. (2022). Network hub centrality and working memory performance in schizophrenia. Schizophrenia (Heidelberg, Germany), 8(1), 76. https://doi.org/10.1038/s41537-022-00288-y

Evins AE & Cather C. (2022). Addressing barriers to provision of first-line pharmacotherapy for tobacco use disorder. Psychiatric Services, 74(4), 429-430. https://doi.org/10.1176/appi.ps.20220467

Evins AE, Cather C, Maravic MC, Reyering S, Pachas GN, Thorndike AN, Levy DE, Fung V, Fischer MA, Schnitzer K, Pratt S, Fetters MD, Deeb B, Potter K, Schoenfeld DA. (2022). A pragmatic cluster randomized trial of provider education and community health worker support for tobacco cessation. Psychiatric services (Washington, D.C.), 74(4), 365–373. https://doi.org/10.1176/appi.ps.20220187

Fortuna KL, Wright A, Mois G, Myers A, Kadakia A & Collins-Pisano C. (2022). Feasibility, acceptability, and potential utility of peer-supported ecological momentary assessment among people with serious mental illness: A pilot study. The Psychiatric Quarterly, 93, 717-735. https://doi.org/10.1007/s11126-022-09986-3

Foulds J, Veldheer S, Pachas G, Hrabovsky S, Hameed A, Allen SI, Cather C, Azzouz N, Yingst J, Hammett E, Modesto J, Krebs NM, Lester C, Trushin N, Reinhart L, Wasserman E, Zhu J, Liao J, Muscat JE, Richie JP, Jr, … Evins AE. (2022). The effects of reduced nicotine content cigarettes on biomarkers of nicotine and toxicant exposure, smoking behavior and psychiatric symptoms in smokers with mood or anxiety disorders: A double-blind randomized trial. PloS one, 17(11), e0275522. https://doi.org/10.1371/journal.pone.0275522  

Gilman JM, Schmitt W, Potter K, Kendsior B, Pachas GN, Hickey S, Makary M, Huestis MA, Evins AE. (2022). Identification of delta-9 tetrahydrocannabinol intoxication using functional brain imaging. Neuropsychopharmacology, 47, 944–952. https://doi.org/10.1038/s41386-021-01259-0

Gilman JM, Schuster RM, Potter K, Schmitt W, Wheeler G, Pachas GN, Hickey S, Cooke ME, Dechert A, Plummer R, Tervo-Clemmens B, Schoenfeld DA, Evins AE. (2022). Effect of medical marijuana card ownership on pain, insomnia, and affective disorder symptoms in adults: A randomized controlled trial. JAMA Network Open, 5(3), e222106. https://doi.org/10.1001/jamanetworkopen.2022.2106

Holt DJ, Zapetis SL, Badabi B, Zimmerman JE &Tootell RBH. (2022).  Personal space increases during the COVID-19 pandemic in response to real and virtual humans. Frontiers in Psychology, 14, 952998.https://doi.org/10.3389%2Ffpsyg.2022.952998

Japuntich SJ, Adkins-Hempel M, Lundtvedt C, Becker SJ, Helseth SA, Fu SS, Tidey J, Evins AE & Pratt R. (2022). Implementing chronic care model treatments for cigarette dependence in community mental health clinics. Journal of dual diagnosis, 18(3), 153–164. https://doi.org/10.1080/15504263.2022.2090647

Jashinski J, Evins AE, Gilman J. (2022). A randomized, pragmatic, waitlist-controlled trial of cannabis added to prescription opioid support on opioid dose reduction and pain in adults with chronic non-cancer pain: Study protocol. BMJ open, 12(6), e064457. https://doi.org/10.1136/bmjopen-2022-064457

Keuroghlian AS & Radix AE. (2022). A cautionary tale: The doomed gender identity clinic at Johns Hopkins Hospital. Annals of internal medicine, 175(10), 1483–1484.  https://doi.org/10.7326/M22-2636

Kim G-W, Farabaugh AH, Vetterman R, Holmes A, Nyer M, Nasiriavanaki Z, Fava M, Holt DJ. (2022). Diminished frontal pole size and functional connectivity in young adults with high suicidality. Journal of Affective Disorders, 310, 484–492. https://doi.org/10.1016/j.jad.2022.04.069

Lim C, Donovan A, Harrold G & Freudenreich O. (2022). A case of undetected seizure disorder that exacerbated catatonia and treatment-resistant schizophrenia: Comprehensive evaluation is key. Prim Care Companion CNS Disord, 24(00):22cr03282. https://doi.org/10.4088/PCC.22cr03282  

Lim C, Van Alphen M, Maclaurin S, Mulligan C, Macri B, Cather C, Freudenreich O (2022). Increasing COVID-19 vaccination rates among patients with serious mental illness: A pilot intervention study. Psychiatric Services (Washington, D.C.), 73(11), 1274-1277. https://doi.org/10.1176/appi.ps.202100702

Onyeaka HK, Seeber R, Anugwom G, Oladunjoye AF, Kekere V, Firth J & Evins AE. (2022). Association between court-ordered corrective statements and smoking cessation among individuals with depression or anxiety. Psychiatry Research Communications, 2(4), 100091.https://doi.org/10.1016/j.psycom.2022.100091

Qi W, Marx J, Zingman M, Li Y, Petkova E. Blessing E, Ardekani B, Kani SA, Cather C, Freudenreich O, Holt D, Zhao J, Wang J & Goff DC. (2022). Hippocampal subfield volumes predict disengagement from maintenance treatment in first episode schizophrenia. Schizophrenia Bulletin, 49(1), 34–42. https://doi.org/10.1093/schbul/sbac043

Srinivasan S, Goldhammer H, Crall C, Kitts R & Keuroghlian AS. (2022) A novel medical student elective course in lesbian, gay, bisexual, transgender, queer, intersex, asexual, and sexually and gender diverse health: Training tomorrow’s physician-leaders. LGBT Health, 10(3), 252–257. https://doi.org/10.1089/lgbt.2022.0161

Tootell RBH, Nasiriavanaki Z, Babadi B, Greve DN, Nasr S & Holt DJ. (2022). Interdigitated columnar representation of personal space and visual space in human parietal cortex. J Neurosci.https://doi.org/JN-RM-0516-22

Wright AC, Browne J, Cather C, Meyer-Kalos P & Mueser KT. (2022) Relationship between patterns of cannabis use and functional and symptomatic trajectories in first-episode psychosis. Eur Arch Psychiatry Clin Neurosci (2022).  https://doi.org/10.1007/s00406-022-01441-5

Wright AC, Cather C, Mueser KT, Farabaugh A, Terechina O, Fava M & Holt D. (2022). Relationships among subclinical psychotic symptoms in young adults over time. Psychiatry Research, 314, 114617.https://doi.org/10.1016/j.psychres.2022.114617

Wright AC, Kritikos K, Bhiku K, LeFeber L, Skiest H, Whitman A, Browne J, Arntz D, Fortuna KL, Mueser KT, Cather C. (2022). The impact of the COVID-19 pandemic on peer specialists. Psychiatric Rehabilitation Journal, 45(3), 201–211. https://doi.org/10.1037/prj0000517

Wright AC, Moody E, Browne J & Cather C. (2022). Self-defining memories among persons with mental health, substance use, cognitive, and physical health conditions: a systematic review. Memory (Hove, England), 30(7), 823–844. https://doi.org/10.1080/09658211.2022.2042565

Wu CA & Keuroghlian AS. (2022). Moving beyond psychiatric gatekeeping for gender-affirming surgery. JAMA surgery, 158(3), 231–232. https://doi.org/10.1001/jamasurg.2022.5828

Zapetis SZ, Nasiriavanaki Z, Luther L, Holt DJ. (2022). Neural correlates of variation in personal space and social functioning in schizophrenia and healthy individuals. Schizophrenia Bulletin.https://doi.org/10.1093/schbul/sbac052

Zimmerman J, DeTore NR, Deng W, Burke AS, Nyer M, Holt DJ. (2022). Worsening of psychotic experiences in college students during the COVID-19 pandemic. Schizophrenia Research, 256, 133–135. https://doi.org/10.1016/j.schres.2022.06.020

Bergman B, Fava M, Evins AE & Kelly JF (2021). Online recovery support meetings can help mitigate the public health consequences of COVID-19 for individuals with substance use disorder. Addictive behaviors, 113, 106661. https://doi.org/10.1016/j.addbeh.2020.106661

Browne J, Cather C & Mueser K. (2021). Common factors in psychotherapy. Oxford Research Encyclopedia of Psychology. doi: 10.1093/acrefore/9780190236557.013.79

Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown HE, Evins AE, Donovan AL. (2021). Developing a sound body: Open trial results of a group healthy lifestyle intervention for young adults with psychosis. Community Mental Health Journal, 57(5):864-871. https://doi.org/10.1007/s10597-020-00655-y

Browne J, Mccurley JL, Fung V, Levy DE, Clark CR & Thorndike AN. (2021). Addressing social determinants of health identified by systemic screening in a Medicaid accountable care organization: A qualitative study. Journal of Primary Care & Community Health, 12:1-8. doi: 10.1177/2150132721993651

Browne J, Wright AC, Berry K, Mueser KT, Cather C, Penn DL & Kurtz M. (2021). The alliance-outcome relationship in individual psychosocial treatment for schizophrenia and early psychosis: A meta-analysis. Schizophrenia Research, 231:154-163. doi: 10.1016/j.schres.2021.04.002

Buck B, Emily EC, Halverson TF, Nagendra A, Ludwig KA, Fortney JC. (2021) A systematic search and critical review of studies evaluating psychometric properties of patient-reported outcome measures for schizophrenia. Journal of Psychiatric Research, 147, 13-23. https://doi.org/10.1016/j.jpsychires.2021.12.053

Cooke ME, Gilman JM, Lamberth E, Rychik N, Tervo-Clemmens B, Evins AE, Schuster RM. (2021). Assessing changes in symptoms of depression and anxiety during four weeks of cannabis abstinence among adolescents. Frontiers in Psychiatry, 12, 689957. https://doi.org/10.3389/fpsyt.2021.689957

Dotson S, Ogbu-Nwobodo L & Shtasel D. (2021). The importance of an evidence-based structural approach in public and community psychiatry. Psychiatric Annals, 51(6). doi: 10.3928/00485713-20210508-01

Evins AE, West R, Benowitz N, Russ C, Lawrence D, McRae T, Maravic MC, Heffner J & Anthenelli RM (2021). Efficacy and tolerability of pharmacotherapeutic smoking cessation aids in those with schizophrenia spectrum disorders: A subgroup analysis of EAGLES. Psychiatric Services, 72(1), 7–15. https://doi.org/10.1176/appi.ps.202000032

Freudenreich O, Kontos N & Querques J. (2021). Ethics in public and community psychiatry. Psychiatric Annals, 51(6):272-277. doi: 10.3928/00485713-20210511-04

Holt DJ & DeTore NR. (2021). Prevention of psychiatric illness in the community: Seeds of change. Psychiatric Annals, 51(6):255-260. doi: 10.3928/00485713-20210511-01

Levy S, Evins AE, Schuster RM, Green L, Lunstead J, Fuller A, Needles EW, Weitzman ER. Virtual group therapy programs- The wave of the future. (2021). Journal of Adolescent Health. 69(3):527.https://doi.org/10.1016/j.jadohealth.2021.05.018

Lim C, Van Alphen MU & Freudenreich O. (2021). Becoming vaccine ambassadors: A new role for psychiatrists. Current Psychiatry, 20(8):10-11,17-21,26-28,38 | doi: 10.12788/cp.0155

MacLaurin SA, Ujkaj M, Mulligan C & Freudenreich O. Optimal long-acting injectable antipsychotic management during COVID-19 [Brief report]. (2021). The Journal of Clinical Psychiatry, 82(1):20|13730. doi: 10.4088/JCP.20l13730

Nagendra A, Halverson T, Pinkham AE, Harvey PD, Jarskog LF, Weisman AM & Penn DL. (2021). Black Americans with schizophrenia: The effects of neighborhood socioeconomic status on domains of functioning. Schizophrenia Research, 224, 95-101. doi: 10.1016/j.schres.2020.09.020

Oh H, Nagendra A, Besecker M, Smith L, Koyanagi A & Wang SJ. (2021). Economic strain, parental education and psychotic experiences among college students in the United States: Findings from the Healthy Minds Study 2020. Acta Early Intervention in Psychiatry, https://doi.org/10.1111/eip.13221

Schnitzer K, Cather C, Potter K, Kaba H, Marsden J, Hoffman D & Shtasel D. (2021). For homeless persons with serious mental illness, can a state transitional shelter promote racial equity in housing outcomes? Journal of Healthcare for the Poor and Underserved, 32(1):232-244. doi: 10.1353/hpu.2021.0021

Schnitzer K, MacLaurin S, & Freudenreich O (2021). Long-acting injectable antipsychotics during the COVID-19 pandemic. Current Psychiatry, 20(2), 8-13. doi:10.12788/cp.0087

Surya S, Bishnoi RJ, Beesam Shashank R, Miller BJ, Freudenreich O, McEvoy JP. (2021). Monitoring for myocarditis during treatment initiation with clozapine. Acta Psychiatr Scand, 144(2):194-200. doi: 10.1111/acps.13328

Wang J, Hart KL, Qi W, Ardekani BA, Li C, Marx J, Freudenreich O, Cather C, Holt D, Bello I, Diminich ED, Tang Y, Worthington M, Zeng B, Wu R, Fan X, Zhao J, Wang J & Goff DC. (2021). Association of aripiprazole with reduced hippocampal atrophy during maintenance treatment of first-episode schizophrenia. Journal of Clinical Psychopharmacol, 41(3):244-249. doi: 10.1097/JCP.0000000000001391

Wright AC, Browne J, Skiest H, Bhiku K, Baker JT & Cather C. (2021). The relationship between conventional clinical assessments and momentary assessments of symptoms and functioning in serious mental illness: A systematic review. Schizophrenia Research. doi: 10.1016/j.schres.2021.04.010

Wright AC, Cather C, Farabaugh A, Terechina O, Pedrelli P, Nyer M., … & Holt DJ. (2021). Relationship between cannabis use and psychotic experiences in college students. Schizophrenia Research, 231, 198-204. https://doi.org/10.1016/j.schres.2021.04.004

Wright AC, Lysaker PH, Fowler D & Greenwood K. (2021). Clinical insight in first episode psychosis: The role of metacognition. Journal of Mental Health. doi: 10.1080/09638237.2021.1922629

Wright AC, McGurk SR, Shaya Y, Feldman K & Mueser KT. (2021). Does comprehensive cognitive remediation improve emotion perception?. Cognitive Neuropsychiatry, 26(5), 343-356. https://doi.org/10.1080/13546805.2021.1946386

Abplanalp SJ, Mueser KT & Fulford D. (2020). The role of physical pain in global functioning of people with serious mental illness. Schizophrenia Research, 222, 423-428. doi: 10.1016/j.schres.2020.03.062.

Bartels SJ, Baggett TP, Freudenreich O & Bird BL. (2020). COVID-19 emergency reforms in Massachusetts to support behavioral health care and reduce mortality of people with serious mental illness. Psychiatric Services, 71(10), 1078-1081. doi: 10.1176/appi.ps.202000244.

Beard E, Jackson SE, Anthenelli RM, Benowitz NL, St Aubin L, McRae T, Lawrence D, Russ C, Krishen A, Evins AE & West R (2021). Estimation of risk of neuropsychiatric adverse events from varenicline, bupropion, and nicotine transdermal patch versus placebo: Secondary analysis of results from the EAGLES trial using Bayes factors. Addiction, 116(10), 2816-2824. https://doi.org/10.1111/add.15440

Browne J, Cather C, Zvonar V, Thayer K, Skiest H, Arntz D, Kritikos K, Schnitzer K, Brown H, Evins AE & Donovan A (2020). Developing a sound body: Open trial results of a group healthy lifestyle intervention for young adults with psychosis. Community Mental Health Journal 57(5), 864–871. https://doi.org/10.1007/s10597-020-00655-y

Browne J, Sanders AS, Friedman-Yakoobian M, Guyer M, Keshavan M, Kim B & Kline E. (2020). Implementation case study: Multifamily group intervention in first-episode psychosis programs. Early Intervention in Psychiatry, 1-7. doi: 10.1111/eip.13066

Burke A, Shapero BG, Pelletier-Baldelli A, Deng YW, Nyer MB, Leathem L, Namey L, Landa C, Cather C & Holt DJ (2020). Rationale, methods, feasibility, and preliminary outcomes of a transdiagnostic prevention program for at-risk college students. Frontiers in Psychiatry. doi: 10.3389/fpsyt.2019.01030

Daumit GL, Dalcin AT, Dickerson FB, Miller ER, Evins AE, Cather C, Jerome GJ, Young DR, Charleston JB, Gennusa JV, Goldsholl S, Cook C, Heller A, McGinty EE, Crum RC, Appel LJ & Wang NY (2020). Effect of a comprehensive cardiovascular risk reduction intervention in persons with serious mental illness: A randomized clinical trial. JAMA Network Open. doi: 10.1001/jamanetworkopen.2020.7247

Donovan AL, Aaronson EL, Black L, Fisher SA, Bird SA, Benzer T & Temin ES. (2020). Keeping patients at risk for self-harm safe in the emergency department: A protocolized approach. The Joint Commission Journal on Quality and Patient Safety, S1553-7250(20)30215-4. doi: 10.1016/j.jcjq.2020.08.013

Dotson S, Hartvigsen N, Wesner T, Fricchione G, & Freudenreich O (2020). Clozapine toxicity in the setting of COVID-19. Psychosomatics, 61(5): 577–578. https://doi.org/10.1016%2Fj.psym.2020.05.025

Evins AE, West R, Benowitz N, Russ C, Lawrence D, McRae T, Maravic MC, Heffner J & Anthenelli R. (2020). Efficacy and safety of pharmacotherapeutic smoking cessation aids in schizophrenia spectrum disorders: Subgroup analysis of EAGLES. Psychiatric Services, 72(1). doi: 10.1176/appi.ps.202000032

Freudenreich O, Kontos N & Querques J. (2020). COVID-19 and patients with serious mental illness. Current Psychiatry, 19(9):24-27, 33-39. doi: 10.12788/cp.0036

Gaudiano, B. A., Ellenberg, S., Ostrove, B., Johnson, J., Mueser, K. T., Furman, M., & Miller, I. W. (2020). Feasibility and preliminary effects of implementing acceptance and commitment therapy for inpatients with psychotic-spectrum disorders in a clinical psychiatric intensive care setting. Journal of cognitive psychotherapy, 34(1), 80–96. https://doi.org/10.1891/0889-8391.34.1.80

Halstead EJ, Leavitt VM, Fiore D & Mueser KT. (2020). A feasibility study of a manualized resilience-based telehealth program for persons with multiple sclerosis and their support partners. Multiple Sclerosis Journal – Experimental, Translational and Clinical, 6(3), 2055217320941250. doi: 10.1177/2055217320941250

Halstead EJ, Stanley J, Fiore D & Mueser KT. (2020). The impact of cognitive impairment in adults with multiple sclerosis (MS) and their family caregivers. International Journal of MS Care, 23(3), 93-100. doi: 10.7224/1537-2073.2019-091

Katz TC, Wozniak J & Freudenreich O. (2020). Challenges of electronic medication entry-working toward reconciliation: A case-based discussion. Psychosomatics, 61(6):808-813. doi: 10.1016/j.psym.2020.02.001

Khare C, Mueser KT, Fulford D, Watve VG, Karandikar NJ, Khare S, Karandikar DN & McGurk SR. (2020).Employment functioning in people with severe mental illnesses living in urban vs. rural areas in India. Social Psychiatry and Psychiatric Epidemiology. 55(12), 1593-1606. doi: 10.1007/s00127-020-01901-0

Marques L*, Youn S*, Zepeda ED, Chablani-Medley A, Bartuska AD, Baldwin M & Shtasel DL. (2020). Effectiveness of a modular cognitive behavioral skills curriculum in high-risk justice-involved youth. The Journal of Nervous and Mental Disease, 208(12), 925-932. doi: 10.1097/NMD.0000000000001232

Schnitzer K, Cather C, Thorndike AN, Potter K, Freudenreich O, MacLaurin S, Vilme M, Dechert A, Wexler D & Evins AE (2020). Improved glycemic control and other diabetes relevant outcomes in adults with serious mental illness and diabetes with an open sixteen-week, reverse integrated care, behavioral and educational intervention. Psychiatric Services. doi: 10.1176/appi.ps.201900336

Schnitzer K, Merideth F, Macias-Konstantopoulos W, Hayden D, Shtasel D & Bird S (2020). Disparities in care: The role of race on the utilization of physical restraints in the emergency setting. Academic Emergency Medicine, 27(10), 943–950. https://doi.org/10.1111/acem.14092

Siskind D, Honer W, Clark S, Correll C, Hasan A, Howes O, Kane J, Kelly DL, Laitman R, Lee J, Maccabe, J, Myles N, Nielsen J, Schulte F, Taylor D, Verdoux H, Wheeler A & Freudenreich O (2020). Consensus statement on the use of clozapine during the COVID-19 pandemic. Journal of Psychiatry & Neuroscience, 45(4), 200061. Advance online publication. https://doi.org/10.1503/jpn.200061

Turner DT., Reijnders M, van der Gaag M, Karyotaki E, Valmaggia LR., Moritz S, Lecomte T, Turkington D, Penadés R, Elkis H, Cather C, Shawyer F, O’Connor K, Li Z, de Paiva Barretto EM & Cuijpers P (2020). Efficacy and moderators of cognitive behavioural therapy for psychosis versus other psychological interventions: An individual-participant data meta-analysis. Frontiers in Psychiatry, 11. doi: 10.3389/fpsyt.2020.00402

Worthington MA, Petkova E, Freudenreich O, Cather C, Holt D, Bello I, Diminich E, Tang Y, Ardekani BA, Zengi B, Wu R, Fan X, Zhao J, Wang J & Goff DC (2020). Air pollution and hippocampal atrophy in first episode schizophrenia. Schizophrenia Research, 218, 63–69. https://doi.org/10.1016/j.schres.2020.03.001

Wright AC, Browne J, Cather C, Pratt S, Bartels S & Mueser K. (2020). Does self-efficacy predict functioning in older adults with schizophrenia? A cross-sectional and longitudinal mediation analysis. Cognitive Therapy and Research, 45, 136-148. doi: 10.1007/s10608-020-10171-8.

Wright AC, Browne J, Mueser KT, & Cather C. (2020). Evidence-Based Psychosocial Treatment for Individuals with Early Psychosis. Child and adolescent psychiatric clinics of North America, 29(1), 211–223. https://doi.org/10.1016/j.chc.2019.08.013

Wright AC, Cather, C., & Evins AE. (2020). Role of cannabis in youth onset psychosis and the changing landscape of this topic. Child and adolescent psychiatric clinics of North America, 29(1), 145–156. https://doi.org/10.1016/j.chc.2019.08.016

Wright AC, Coman D, Deng W, Farabaugh A, Terechina O, Cather C, Fava M & Holt D (2020). The impact of childhood trauma, hallucinations, and emotional reactivity on delusional ideation. Schizophrenia Bulletin Open. doi: 10.1093/schizbullopen/sgaa021

Youn SJ, Aguilar-Silvan Y, Baldwin M, Chablani-Medley A, Patrick KA, Shtasel DL & Marques L (2020). Ensuring the fit of an evidence-based curriculum for high-risk Latina young mothers using implementation science. Journal of Community Psychology, 49(2), 737–755. https://doi.org/10.1002/jcop.22321

Achtyes, E. D., Ben-Zeev, D., Luo, Z., Mayle, H., Burke, B., Rotondi, A. J., Gottlieb, J. D., Brunette, M.F., Mueser, K.T., Gingerich, S., Meyer-Kalos, P.S., Marcy, P., Schooler, N.R., Robinson, D.E., & Kane, J.M. (2019). Off-hours use of a smartphone intervention to extend support for individuals with schizophrenia spectrum disorders recently discharged from a psychiatric hospital. Schizophrenia Research, 206, 200-8. https://doi.org/10.1016/j.schres.2018.11.026.

Ayers CR, Heffner JL, Russ C, Lawrence D, McRae T, Evins AE & Anthenelli RM (2019). Efficacy and safety of pharmacotherapies for smoking cessation in anxiety disorders: Subgroup analysis of the randomized, active- and placebo-controlled EAGLES trial. Depression and Anxiety. doi: 10.1002/da.22982.

Browne J, Bass, E., Mueser KT, Meyer-Kalos, P., Gottlieb, J.D., Estroff, S.E., & Penn, D.L. (2019). Client predictors of the therapeutic alliance in individual resiliency training for first episode psychosis. Schizophrenia Research, 204, 375-80. doi: 10.1016/j.schres.2018.07.035

Browne J, Mueser KT, Meyer-Kalos, P., Gottlieb, J.D., Estroff, S.E., & Penn, D.L. (2019). The therapeutic alliance in individual resiliency training for first episode psychosis: Relationship with treatment outcomes and therapy participation. Journal of Consulting and Clinical Psychology, 87(8): 734-744. https://doi.org/10.1037/ccp0000418

DeCross, S.N., Farabaugh, A. H., Holmes, A.J., Ward, M., Boeke, E. A., Wolthusen, R. P. F., Coombs III, G., Nyer, M., Fava, M., Buckner, R. L., Holt, D. J. (2019). Increased amygdala-visual cortex connectivity in youth with persecutory ideation. Psych Med, 12:1-11. doi: 10.1017/S0033291718004221

DeTore, N. R., Gottlieb, J. D., & Mueser, K. T. (2019). Prevalence and correlates of PTSD in first episode psychosis: Findings from the RAISE-ETP study. Epub at Psychological services, 18(2), 147–153. https://doi.org/10.1037/ser0000380

DeTore, N. R., Mueser, K. T., Byrd, J. A., & McGurk, S. R. (2019). Cognitive functioning as a predictor of response to comprehensive cognitive remediation. Journal of Psychiatric Research, 113: 117-24. https://doi.org/10.1016/j.jpsychires.2019.03.012

Evins, A. E., Cather, C., & Daumit, G. L. (2019). Smoking cessation in people with serious mental illness. The Lancet Psychiatry. http://dx.doi.org/10.1016/S2215-0366(19)30139-7  

Evins AE, Cather, C., & Daumit, G. (2019). Tailored intervention to improve engagement of smokers with severe mental illness in cessation services. Lancet Psychiatry, 6(7): 563-564. https://doi.org/10.1016/S2215-0366(19)30139-7

Gilman, J.M., Yücel, M.A., Pachas, G.N., Potter, K., Levar, N., Broos, H., Manghis, E.M., Schuster, R.M., & Evins A.E. (2019). Delta-9-tetrahydrocannabinol intoxication is associated with increased prefrontal activation as assessed with functional near-infrared spectroscopy: A report of a potential biomarker of intoxication. NeuroImage. https://doi.org/10.1016/j.neuroimage.2019.05.012

Goff, D.C., Freudenreich, O., Cather, C., Holt, D., Bello, I., Diminich, E., Tang, Y., Ardekani, B.A., Worthington, M., Zeng, B., & Wu, R. (2019). Citalopram in first episode schizophrenia: The DECIFER trial. Schizophrenia research, 208, 331-337. https://doi.org/10.1016/j.schres.2019.01.028

Lecomte, T., Potvin, S., Samson, C., Francoeur, A., Hache-Labelle, C., Boucher, J., Bouchard, M., Gagné, S., & Mueser, K. T. (2019). Predicting and preventing symptom onset in schizophrenia: A meta-review of current empirical evidence. Journal of Abnormal Psychology, 128(8):840-854. https://doi.org/10.1037/abn0000447

Marques, L., Valentine, S.E., Kaysen, D., Mackintosh, M.A., De Silva, D., Louise, E., Ahles, E.M., Youn, S.J., Shtasel, D.L., Simon, N.M., & Wiltsey-Stirman, S. (2019). Provider fidelity and modifications to cognitive processing therapy in a diverse community health clinic: Associations with clinical change. Journal of consulting and clinical psychology, 87(4), 357. http://dx.doi.org/10.1037/ccp0000384

Martinez, L.S., Lundgren, L., Walter, A.W., Sousa, J., Tahoun, N., Steketee, G., Hahm, H., Mueser KT, Krull, I., Do, D.L., & Saitz, R. (2019). Behavioral health, primary care integration, and social work’s role in improving health outcomes in communities of color: A systematic review. Journal of the Society for Social Work & Research, 10, 2334-15. https://psycnet.apa.org/doi/10.1086/704070

Mueser KT, DeTore NR, Kredlow M, Penn DL & Hintz K (2019). Clinical and demographic correlates of stigma in first-episode psychosis: the impact of duration of untreated psychosis. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/acps.13102

Mueser KT, Meyer-Kalos, P.S., Glynn, S.M., Lynde, D.W., Robinson, D.G., Gingerich, S., Penn, D.L., Cather, C., Gottlieb, J.D., Marcy, P., & Wiseman, J.L. (2019). Implementation and fidelity assessment of the NAVIGATE treatment program for first episode psychosis in a multi-site study. Schizophrenia research, 204, 271-281. https://doi.org/10.1016/j.schres.2018.08.015

Nishith, P., Mueser, K. T., & Morse, G. A. (2019). Alcohol expectancies in persons with severe mental illness and posttraumatic stress disorder. Cogent Medicine, 6, 1635805. http://dx.doi.org/10.1080/2331205X.2019.1635805

Schuster RM, Potter K, Vandrey R, Hareli M, Gilman JM, Schoenfeld D & Evins AE (2019). Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent cannabis users during one month of sustained and biochemically-verified abstinence. Journal of Psychopharmacology. doi: 10.1177/0269881119872206.

Shapero, B.G., Farabaugh, A., Terechina, O., DeCross, S.N,, Cheung, J., Fava, M., Holt, D.J. (2019). Understanding the effects of emotional reactivity on depression and suicidal thoughts and behaviors: moderating effects of childhood adversity and resilience. J Affect Disord, 419-427. doi: 10.1016/j.jad.2018.11.033

Tidey J, Muscat J, Foulds J, Evins AE, Gaalema DE & Denlinger-Apte RL (2019). Reducing the nicotine content of cigarettes: Effects in smokers with mental health conditions and socioeconomic disadvantages. Nicotine & Tobacco Research. doi: 10.1093/ntr/ntz118.

Tuominen, L., Boeke, E.A., DeCross, S.N., Wolthusen, R.P.F., Nasr, S., Milad, M.M., Vangel, M., Tootell, R.B.H., Holt, D.J. (2019) The relationship of perceptual discrimination to neural mechanisms of fear generalization. NeuroImage, 445. https://doi.org/10.1016/j.neuroimage.2018.12.034

Valentine, S.E., Ahles, E.M., De Silva, L.E.D., Patrick, K.A., Baldwin, M., Chablani-Medley, A., Shtasel, D.L., & Marques, L. (2019). community-based implementation of a paraprofessional-delivered cognitive behavioral therapy program for youth involved with the criminal justice system. Journal of Health Care for the Poor and Underserved, 30(2), 841-865. https://doi.org/10.1353/hpu.2019.0059

Vance, M., Bui, E., Shtasel, D., & Borba, C. (2019). Health advocacy among resident physicians. MedEdPublish, 8. https://doi.org/10.15694/mep.2019.000029.1

Wright A, Browne J, Mueser KT & Cather C (2019). Evidence-based psychosocial treatment for individuals with early psychosis. Child and Adolescent Psychiatric Clinics of North America. doi: 10.1016/j.chc.2019.08.013.

Wright A, Cather C, Gilman J & Evins AE (2019). The changing legal landscape of cannabis use and its role in youth-onset psychosis. Child and Adolescent Psychiatric Clinics of North America. doi: 10.1016/j.chc.2019.08.016.

Wright AC, Fowler D & Greenwood K (2019). Influences on functional outcome and subjective recovery in individuals with and without first episode psychosis: A metacognitive model. Psychiatry Research. doi: 10.1016/j.psychres.2019.112643.

Wright AC, Nelson B, Fowler D & Greenwood K (2019). Perceptual biases and metacognition and their association with anomalous self experiences in first episode psychosis. Consciousness and Cognition. doi: 10.1016/j.concog.2019.102847.

Wright, A.C., Davies, G., Fowler, D., & Greenwood, K. (2019). Three-year follow-up study exploring metacognition and function in individuals with first episode psychosis. Frontiers in Psychiatry, 10, 182. https://doi.org/10.3389/fpsyt.2019.00182

Wright, A.C., Mueser KT, McGurk, S.R., Fowler, D., & Greenwood, K. E. (2019). Cognitive and metacognitive factors predict engagement in employment in individuals with first episode psychosis. Schizophrenia Research: Cognition, 100141. https://doi.org/10.1016/j.scog.2019.100141

Yeh CL, Levar N, Broos HC, Dechert A, Potter K, Evins AE & Gilman JM (2019). White matter integrity differences associated with posttraumatic stress disorder are not normalized by concurrent marijuana use. Psychiatry Research: Neuroimaging. doi: 10.1016/j.pscychresns.2019.111017.

Youn S, Mackintosh M, Wiltsey Stirman S, Patrick KA, Aguilar Silvan Y, Bartuska AD, Shtasel DL & Marques L (2019). Client-level predictors of treatment engagement, outcome, and dropout: Moving beyond demographics. General Psychiatry. doi: 10.1136/gpsych-2019-100153.

Youn, S.J., Sauer-Zavala, S., Patrick, K.A., Ahles, E.M., Aguilar, S.Y., Greig, A., Marques, L., & Shtasel, D.L. (2019). Barriers and facilitators to implementing a short-term transdiagnostic mental health treatment for homeless persons. The Journal of Nervous and Mental Disease. https://doi.org/10.1097/nmd.0000000000001010

Dalcin, A.T., Jerome, G.J., Appel, L.J., Dickerson, F.B., Wang, N.Y., Miller, E.R., Young, D.R., Charleston, J.B., Gennusa, J.V., Goldsholl, S., Heller, A., Evins, A.E., Cather, C., McGinty, E.E., Crum, R.M., & Daumit, G.L. (2018). Need for cardiovascular risk reduction in persons with serious mental illness: design of a comprehensive intervention. Frontiers in Psychiatry, 9. http://dx.doi.org/10.3389/fpsyt.2018.00786